Related Experiment Video
Updated: Jun 17, 2026

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach
Published on: June 11, 2017
Effect of ampicillin on the bleeding time of neonatal intensive care unit patients
M J Sheffield1, D K Lambert, E Henry
1Department of Neonatology, Intermountain Healthcare, McKay-Dee Hospital Center, Ogden, UT 84403, USA. Mark.sheffield@imail.org
Objective:
Studies in adults indicate that ampicillin, in a dose-dependent manner, impairs platelet function and moderately prolongs the bleeding time (generally by 60 to 90 s). Unlike aspirin, the inhibition induced by ampicillin involves both reversible and irreversible mechanisms and is not observed immediately after initial dosing (generally requiring approximately 24 h). Ampicillin is administered commonly to neonatal intensive care unit (NICU) patients, but its effect on bleeding time in this population has not been reported earlier.
Study Design:
We performed neonatal template bleeding times and platelet function analyzer (PFA)-100 tests on 15 NICU patients before and at various intervals after intravenous ampicillin dosing.
Result:
Neonates were only studied if no beta-lactam antibiotics were administered to their mother during labor, and if they had ampicillin ordered by the clinician at a dose of 50 to 100 mg kg(-1) every 12 h. Subjects ranged from 33 to 41 weeks gestation and weighed 1760 to 3835 g. Bleeding times before the first ampicillin dose (n=15) averaged 134 s (95% confidence interval (CI), 120 to 148 s) and PFA-100 times averaged 123 s (95% CI, 96 to 149 s). After the first dose of ampicillin (n=5), bleeding times and PFA-100 times did not increase, but after the third (n=5) and fourth doses (n=4) bleeding times lengthened by an average of 60 s (95% CI, 37 to 83 s, P<0.001) and PFA-100 times lengthened by an average of 20 s (95% CI, -20 to 60 s, P=0.15).
Conclusion:
Ampicillin administered intravenously to NICU patients prolongs the bleeding time, with a magnitude-of-effect and time-to-effect similar to that shown earlier in adults.
Insights
Intravenous ampicillin in neonatal intensive care unit (NICU) patients prolongs bleeding time, similar to adults. This effect is dose-dependent and takes approximately 24 hours to manifest, impacting platelet function.
Area of Science:
- Neonatal pharmacology
- Hematology
- Clinical pharmacology
Background:
- Ampicillin is commonly used in neonatal intensive care units (NICUs).
- Adult studies show ampicillin impairs platelet function and prolongs bleeding time in a dose-dependent manner.
- The effect on bleeding time in NICU patients has not been previously reported.
Purpose of the Study:
- To investigate the effect of intravenous ampicillin on bleeding time in neonatal intensive care unit (NICU) patients.
- To compare the ampicillin-induced changes in bleeding time in neonates to those observed in adults.
Main Methods:
- Neonatal template bleeding times and Platelet Function Analyzer (PFA)-100 tests were conducted on 15 NICU patients.
- Tests were performed before and at various intervals after intravenous ampicillin administration.
- Patients received ampicillin at 50-100 mg/kg every 12 hours; mothers did not receive beta-lactam antibiotics during labor.
Main Results:
- Before ampicillin, mean bleeding time was 134 seconds and mean PFA-100 time was 123 seconds.
- Following the first ampicillin dose, no significant increase in bleeding or PFA-100 times was observed.
- After the third and fourth doses, bleeding times increased by an average of 60 seconds (P<0.001), while PFA-100 times showed a non-significant increase.
Conclusions:
- Intravenous ampicillin administration in NICU patients prolongs bleeding time.
- The magnitude and time course of the effect are similar to those previously reported in adult studies.
- Ampicillin's impact on bleeding time in neonates warrants consideration in clinical practice.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...

